Hansa Biopharma Hosts Virtual Event with Renowned Transplant Surgeons Focusing on Imlifidase Phase 3 Results Join Hansa Biopharma for an insightful session featuring leading transplant surgeons discussing the Phase 3 results of Imlifidase, a novel treatment for transplant patients.

Hansa Biopharma Hosts Virtual Event with Renowned Transplant Surgeons Focusing on Imlifidase Phase 3 Results #Sweden #Lund #Hansa_Biopharma #imlifidase #Transplant_Surgeons

Hansa Biopharma Hosts Virtual Event with Leading Transplant Surgeons to Discuss Imlifidase Phase 3 Results Hansa Biopharma's upcoming virtual event on November 12, 2025, will involve insights from top transplant surgeons regarding the Phase 3 results of imlifidase.

Hansa Biopharma Hosts Virtual Event with Leading Transplant Surgeons to Discuss Imlifidase Phase 3 Results #Sweden #Lund #Hansa_Biopharma #imlifidase #Transplant_Surgeons